Seaview Investment Managers LLC Abb Vie Inc. Transaction History

Seaview Investment Managers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $6.29 Million - $8 Million	-45,707 Reduced 95.44%	2,183 $334,000
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $6.32 Million - $7.84 Million	47,890 New	47,890 $7.76 Million
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $4.89 Million - $5.55 Million	-45,960 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $1.18 Million - $1.32 Million	11,232 Added 32.34%	45,960 $5.18 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $67,824 - $74,667	-663 Reduced 1.87%	34,728 $3.76 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $1,046 - $1,412	-13 Reduced 0.04%	35,391 $3.79 Million
Q3 2020 Nov 20, 2020	BUY	$85.91 - $100.83 $3.04 Million - $3.57 Million	35,404 New	35,404 $3.01 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Seaview Investment Managers LLC, based on Form 13F filings with the SEC.

Stay updated on Seaview Investment Managers LLC with notifications on news.